The impact of genetic polymorphisms on time required to attain the target tacrolimus levels and subsequent pharmacodynamic outcomes in pediatric kidney transplant patients

by Sireen Shilbayeh
Published 2014-01-01

Pediatric Renal Transplantation in the Jordanian Population: The Clinical Outcome Measures During Long-term Follow-up Period

by Sireen Shilbayeh, Issa Hazza
Published 2012-02-01

The impact of CYP3A5 and MDR1 polymorphisms on tacrolimus dosage requirements and trough concentrations in pediatric renal transplant recipients

by Sireen Shilbayeh, Rawan Zmeili, Reham Issa Almardini
Published 2013-01-01

Pharmacist-perceived barriers to pharmaceutical care of chronic and end-stage kidney disease patients in Saudi Arabia

by Amal K Suleiman, Maryam Melaibari, Turkiah Alkhaldi, Sara Almuhisen, Samar Alharbi, Abeer Kharshid, Amany Alboghdadly, Sireen Shilbayeh
Published 2016-01-01